Ex Parte Lien et alDownload PDFPatent Trial and Appeal BoardDec 21, 201611574377 (P.T.A.B. Dec. 21, 2016) Copy Citation United States Patent and Trademark Office UNITED STATES DEPARTMENT OF COMMERCE United States Patent and Trademark Office Address: COMMISSIONER FOR PATENTS P.O.Box 1450 Alexandria, Virginia 22313-1450 www.uspto.gov APPLICATION NO. FILING DATE FIRST NAMED INVENTOR ATTORNEY DOCKET NO. CONFIRMATION NO. 11/574,377 03/27/2007 Wen Sze Lien 3712036.00629 3919 29157 7590 12/23/2016 K&T Oates T T .P-Phiraan EXAMINER P.O. Box 1135 CHICAGO, IL 60690 TURNER, FELICIA C ART UNIT PAPER NUMBER 1793 NOTIFICATION DATE DELIVERY MODE 12/23/2016 ELECTRONIC Please find below and/or attached an Office communication concerning this application or proceeding. The time period for reply, if any, is set in the attached communication. Notice of the Office communication was sent electronically on above-indicated "Notification Date" to the following e-mail address(es): USpatentmail@klgates.com PTOL-90A (Rev. 04/07) UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD Ex parte WEN SZE LIEN, ZHU GAO, YONG FU WANG, BEATRICE LADO, YAN XI JIN, FABIEN ROBERT, AHMED BOUSBAINE, NADJI REKHIF, and CHRISTOPHER BRIMELOW1 Appeal 2015-006768 Application 11/574,377 Technology Center 1700 Before BRADLEY R. GARRIS, KAREN M. HASTINGS, and MONTE T. SQUIRE, Administrative Patent Judges. GARRIS, Administrative Patent Judge. DECISION ON APPEAL Appellants appeal under 35 U.S.C. § 134 from the Examiner’s decision rejecting claims 1—6, 10, and 12—24. We have jurisdiction under 35 U.S.C. § 6. We AFFIRM. 1 Nestec S.A. is identified as the real party in interest. App. Br. 2. Appeal 2015-006768 Application 11/574,377 Appellants claim a shelf-stable concentrate cooking aid (independent claim 1), a method of using such a cooking aid (independent claims 17, 21, and 22) and a process for preparing such a cooking aid (independent claims 18 and 20). The cooking aid may comprise Xian characteristics (dependent claim 3 and independent claim 22). A copy of representative claims 1 and 3, taken from the Claims Appendix of the Appeal Brief, appears below. 1. A shelf-stable concentrate cooking aid comprising MSG in an amount from about 1.0% to about 2.0% by weight; IMP in an amount from about 0.05% to about 0.1%; GMP in an amount from about 0.05% to about 0.1%; sodium chloride; between 10 and 20 % by weight of food derived acids and carbohydrates; and between 20 and 45 % by weight macromolecules comprising polysaccharides, proteins, and fats, wherein the polysaccharides are present in an amount from about 8% to about 20% and the proteins are present in an amount from about 8% to about 20%, and the MSG, the IMP, the GMP, the food derived acids, the carbohydrates and the macromolecules are provided by a raw product used to produce the shelf-stable concentrate cooking aid, the raw product selected from the group consisting of vegetables, meat and a combination thereof. 3. The shelf stable cooking aid according to claim 1, comprising Xian sensory characteristics. The Examiner rejects claims 3 and 22 under the 2nd paragraph of 35 U.S.C. § 112 as being indefinite (Final Action 2). Under 35 U.S.C. § 103(a), the Examiner rejects as unpatentable: claims 1—6, 10, 13—17, 20—22, and 24 over Schoenmaker et al. (US 6,190,709 Bl, issued Feb. 20, 2001) (“Schoenmaker”) in view of Emster (US 5,077,062, issued Dec. 31, 1991), Eldridge et al. (Carbohydrate 2 Appeal 2015-006768 Application 11/574,377 Composition of Soybean Flours, Protein Concentrates, and Isolates, 27 J. Agric. Food Chem. 799-802 (1979)) (“Eldridge”), and Huisman et al. (Cell wall polysaccharides from soybean (Glycine max.) meal. Isolation and characterisation, 37 Carbohydrate Polymers 87—95 (1998)) (“Huisman”) {id. at 3—13); claim 12 over these first recited references in combination with Olson et al. (US 3,743,514, issued July 3, 1973) (“Olson”) {id. at 14); claims 18 and 19 over the first recited references in combination with Anderson et al. (US 5,053,234, issued Oct. 1, 1991) (“Anderson”) and JP ’676 (Ochi, JP 58-193676 A, published Nov. 11, 1983) (“JP ’676”) {id. at 14—18); and claim 23 over the first recited references in combination with Yoshida et al. {Participation of Free Fatty Acids in the Oxidation of Purified Soybean Oil During Microwave Heating, 69 JAOCS 1136—1140 (1992)) (“Yoshida”) {id. at 18—19). In contesting the § 103 rejections, Appellants present arguments specifically directed to the independent claims only with no separate additional arguments of any meaningful specificity directed to the dependent claims (App. Br. 14—29). Therefore, in assessing these § 103 rejections, the dependent claims will stand or fall with their parent independent claims of which claim 1 is representative. We sustain each of the above rejections for the reasons expressed in the Final Action, the Answer, and below. The $ 112, 2nd paragraph. Rejection The Examiner considers the recitation “‘Xian characteristics’” to render claims 3 and 22 indefinite because the phrase has not been adequately defined in the Specification and because the Specification discloses that the 3 Appeal 2015-006768 Application 11/574,377 objective description and characterization of the term Xian “still remains unclear” (Final Action 2 (referring to original Spec. 3:1—4 and published Spec. 1 5)). Appellants argue “the specification disclose[s] that ‘Xian is a taste descriptor well understood and frequently used in Chinese culinary food culture’ (emphasis added)” (App. Br. 12) and that “the skilled artisan would immediately appreciate what is meant by the phrase ‘Xian characteristics’” (id. at 14). The original Specification disclosure teaches: “The so called XIAN expression is well understood and commonly used in Chinese culinary culture but its objective description and characterization still remains unclear since it seems to go beyond the umami dimension.” (Original Spec. 3:1—5). This Specification teaching supports the Examiner’s indefmiteness determination. This determination also is supported by the Specification disclosure that “deliciousness is a subjective attribute” (original Spec. 2:9- 10) and that “the expression XIAN is the one that corresponds and describes to the best as deliciousness” (id. at 2:31—32). These Specification disclosures evince that the claim phrase “Xian characteristics” is a subjective attribute whose objective description and characterization remain unclear. For these reasons, claims 3 and 22 viewed in light of Appellants’ Specification do not “inform those skilled in the art about the scope of the invention with reasonable certainty.” Nautilus, Inc. v. Biosig Instruments, Inc., 134 S. Ct. 2120, 2129 (2014). In support of their definiteness position, Appellants also make reference to the Specification disclosure of typical Xian organoleptic descriptors (App. Br. 12—13) and reference to “a graphical representation of 4 Appeal 2015-006768 Application 11/574,377 umami/xian degree and Xian” (id. at 13).2 3However, these references fail to provide the reasonable certainty required by the 2nd paragraph of § 112. Based on the record before us, we agree with the Examiner that claims 3 and 22 are indefinite. The § 103 Rejections- In rejecting claim 1, the Examiner concludes that it would have been obvious “to include salt in the flavor enhancer of Schoenmaker as in Emster in order to further enhance the flavoring imparting ability” (Final Action 4) and “to modify the flavor enhancer of Schoenmaker to include polysaccharides in the amounts as disclosed in [Ejldridge and Huisman since these are the amounts found in soybean flours and soybean meal and since the polysaccharides would have added to the taste and texture of the flavor enhancer” (id. ). The Examiner further concludes that it would have been obvious to provide Schoenmaker’s MSG, IMP, and GMP in the claimed amounts because such amounts overlap the ranges disclosed by Schoenmaker (id. at 4—5) and likewise obvious to provide Schoenmaker’s proteins in the claimed amounts “since they contribute to the flavor provided by the flavor enhancer and it would have been obvious to optimize for the desired level of flavor enhancement” (id. at 5). We observe that Appellants do not address, and therefore do not identify any error in, the Examiner’s rebuttals of several arguments 2 Based on the record before us, this graphical representation is merely attorney argument unsupported by objective evidence. 3 The indefiniteness of claims 3 and 22 does not prevent us from assessing the § 103 rejection thereof because the Examiner considers the phrase “Xian characteristics” to be an inherent characteristic of these claims and the applied prior art (see, e.g., Final Action 2, 5). 5 Appeal 2015-006768 Application 11/574,377 contesting the § 103 rejections. For example, Appellants acknowledge Schoenmaker discloses IMP and GMP amounts of less than about 0.1% (i.e., within the claim 1 range) but point out Schoenmaker prefers amounts of less than 0.01% (i.e., outside the claim 1 range) and correspondingly argue “Schoenmaker teaches away from the presently claimed amounts” (App. Br. 16). However, Appellants do not address the rebuttal of this argument wherein the Examiner cites legal authority for the proposition that Schoenmaker’s preference does not teach away from the claimed amounts (compare Reply Br. generally with Ans. 20-21). We will not further reiterate such arguments wherein the Examiner’s persuasive rebuttals have not been challenged by Appellants in the record of this appeal. Regarding the polysaccharides limitation of claim 1, Appellants argue “after the thorough enzymatic and fermentative hydrolysis described in Schoenmaker, the skilled person would not expect any polysaccharides would still be present, unless in very minor amounts” (App. Br. 16). Appellants provide no evidence in support of this argument. More importantly, Appellants do not specifically address and show error in the Examiner’s conclusion that it would have been obvious to provide the flavor enhancer of Schoenmaker with polysaccharides in the claimed amounts in view of Eldridge and Huisman because “the polysaccharides would have added to the taste and texture of the flavor enhancer” (Final Action 4). Appellants contend that Schoenmaker discloses 20.25^44.0% proteins which “is well above the presently claimed amounts [i.e., “from about 8% to about 20%” (claim 1)]” (App. Br. 16). Appellants’ contention is not persuasive for a number of reasons. First, Appellants fail to explain why the claim 1 limitation “about 20%” should be interpreted as excluding the 20.25% of Schoenmaker. Second, 6 Appeal 2015-006768 Application 11/574,377 Appellants fail to dispute in their Reply Brief the Examiner’s determination that the 20.25% of Schoenmaker is so close to the “about 20%” of claim 1 that “one of ordinary skill would have expected compositions that are in such close proportions to those in [the] prior art to be prima facie obvious and to have the same properties” (Ans. 22). We emphasize that this determination of the Examiner is supported by established precedent. See Titanium Metals Corp. of America v. Banner, 778 F.2d 775, 783 (Fed. Cir. 1985); see also In re Harris 409 F.3d 1339, 1341 (Fed. Cir. 2005). Appellants further argue “there exists no reason why the skilled artisan would have been motivated to combine the cited references to arrive at the presently claimed subject matter when none of the references even consider Xian characteristics” (App. Br. 18). Appellants’ argument is unconvincing because it is not embellished with any discussion of the reasons expressly articulated by the Examiner for combining the applied references, for example, in order to provide flavor, taste, and texture (Final Action 4). Moreover, this argument is premised on “Xian characteristics” which only claims 3 and 22 recite. Further regarding the “Xian characteristics” of claims 3 and 22, Appellants acknowledge the Examiner’s position that “such a property would have been an inherent characteristic of the composition” (Final Action 5) but apparently consider this position to be erroneous because “Schoenmaker fails to disclose or suggest several elements of the present claims” (App. Br. 18). Contrary to Appellants’ apparent belief, it is not inappropriate to rely on inherency in an obviousness analysis. “[I]n order to rely on inherency to establish the existence of a claim limitation in the prior art in an obviousness analysis—the limitation at issue necessarily must be present, or the natural 7 Appeal 2015-006768 Application 11/574,377 result of the combination of elements explicitly disclosed by the prior art.” PAR Pharm., Inc. v. TWi Pharms., Inc., 773 F.3d 1186, 1195—96 (Fed. Cir. 2014). The Examiner’s proposed combination of the applied prior art would result in a composition within the scope of the appealed claims, and accordingly the “Xian characteristics” of claims 3 and 22 would be the natural result of this proposed combination. Finally, Appellants argue that “it would not have been obvious to modify the amounts of components in Schoenmaker because the Examiner has not demonstrated that any of the presently recited claim elements are result-effective variables” (App. Br. 18—19). “A recognition in the prior art that a property is affected by the variable is sufficient to find the variable result-effective.” In re Applied Materials, Inc. 692 F.3d 1289, 1297 (Fed. Cir. 2012). Here, the fact that Schoenmaker discloses component-amounts, including amount ranges overlapping the claimed ranges, evinces a recognition by Schoenmaker that a property, such as flavor enhancement, of Schoenmaker’s flavor enhancer is affected by the component-amount variable. For this reason, the record reflects that the component-amount variable of Schoenmaker is an art- recognized result-effective variable. For the reasons stated above and given by the Examiner, Appellants’ arguments fail to reveal error in the § 103 rejections before us. Conclusion The decision of the Examiner is affirmed. 8 Appeal 2015-006768 Application 11/574,377 TIME PERIOD FOR RESPONSE No time period for taking any subsequent action in connection with this appeal may be extended under 37 C.F.R. § 1.136(a)(1). AFFIRMED 9 Copy with citationCopy as parenthetical citation